Author

Jens T. Siveke

SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09
SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09

Jens T. Siveke  et al.

TRACKING GENETIC AND TRANSCRIPTOMIC CHANGES IN OESOPHAGEAL ADENOCARCINOMA DURING NEOADJUVANT TREATMENT
TRACKING GENETIC AND TRANSCRIPTOMIC CHANGES IN OESOPHAGEAL ADENOCARCINOMA DURING NEOADJUVANT TREATMENT

Jens T. Siveke  et al.

Item 1 - 2 / 2
1